KLF4 and hepatocellular carcinoma: KLF4 has been shown to be a tumor suppressor in a variety of malignancies, and reduced KLF4 expression has been linked to a worse overall survival rate in hepatocellular carcinoma, pancreatic cancer, and renal cell carcinoma [23].